Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecapegfilgrastim vs rhG-CSF for Neutropenia in Breast Cancer
NCT02119715Phase 2Completed
- Sponsor
- Hengrui
- Start
- Feb 2011
- Primary completion
- Aug 2012
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of mecapegfilgrastim in neutropenia, sponsored by Hengrui. Started Feb 2011; status: completed.
02
Drugs
mecapegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT02119715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02119715.